An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...
Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. Its lead product candidate is AVA6000, a ...
Investing.com -- Akari Therapeutics PLC (NASDAQ:AKTX) stock gained 7.9% in premarket trading Tuesday after the company released preclinical data showing its novel antibody-drug conjugate AKTX-101 ...
Partnership with Kelun-Biotech expands pipeline and accelerates combination strategy with CR-001, a PD-1 x VEGF bispecific ...
U.S. FDA grants waiver of application fee for BLA Filing of OST-HER2Scheduled pre-Marketing Authorisation Application meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results